Ensysce Biosciences, Inc.
USD0.27
+0.00 (+1.30%)
CEO
D. Lynn Kirkpatrick
IPO Date
2018-03-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.26
Prev. Close
$0.26
Day Low
$0.25
Day High
$0.28
52W Low
$0.23
52W High
$2.75
Market Cap
$0.00B
Volume
0.86M
| 270,000 |
| $0.48 |
| 2 Mar 2023 | GOWER BOB G | director | P-Purchase | Acquired | 109,300 | $0.49 |
| 1 Feb 2023 | GOWER BOB G | director | P-Purchase | Acquired | 357,143 | $1.40 |
| 1 Feb 2023 | GOWER BOB G | director | A-Award | Acquired | 714,286 | $1.40 |
| 27 Jun 2022 | Martin Steven Robert | director: | A-Award | Acquired | 15,000 | $0.00 |
| 27 Jun 2022 | Chang William H | director: | A-Award | Acquired | 15,000 | $0.00 |
| 27 Jun 2022 | GOWER BOB G | director: | A-Award | Acquired | 15,000 | $0.00 |
| 27 Jun 2022 | GOWER BOB G | director, 10 percent owner: | A-Award | Acquired | 15,000 | $0.42 |
| 27 Jun 2022 | Rauch Lee M. | director: | A-Award | Acquired | 15,000 | $0.00 |